[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-336083-105":59,"doc-detail-336083-en":134},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":127,"head_meta":129,"extra_data":131,"updated_unix":133},105,"en","panc-1-cell-line-as-an-experimental-model-for-characterizing-pivka-ii-production-distribution-and-molecular-mechanisms-leading-to-protein-release-in-pdac","PANC-1 Cell Line as an Experimental Model for Characterizing PIVKA-II Production, Distribution, and Molecular Mechanisms Leading to Protein Release in PDAC","","Pancreatic ductal adenocarcinoma (PDAC) is an aggressive malignancy lacking reliable diagnostic biomarkers. Protein induced by vitamin K absence (PIVKA-II) has shown superior diagnostic performance for PDAC relative to other biomarkers. This study aimed to establish an in vitro model to study PIVKA-II production, distribution, and release in PDAC. PIVKA-II was assessed across stabilized pancreatic cancer cell lines by Western blot and indirect immunofluorescence, leading to PANC-1 as the reference model. Glucose addiction was then tested for its effect on PIVKA-II production and on release under increasing glucose doses alongside epithelial–mesenchymal transition markers Vimentin and Snail. Results support a glucose-dependent release coupled with EMT activation in PANC-1 cells.",{"@graph":69,"@context":126},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/panc-1-cell-line-as-an-experimental-model-for-characterizing-pivka-ii-production-distribution-and-molecular-mechanisms-leading-to-protein-release-in-pdac/336083/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/panc-1-cell-line-as-an-experimental-model-for-characterizing-pivka-ii-production-distribution-and-molecular-mechanisms-leading-to-protein-release-in-pdac/336083.png","ImageObject",300,407,{"name":92,"@type":93},"Lucas Martin","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-30","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118,122],{"name":109,"@type":110,"acceptedAnswer":111},"What is the purpose of using the PANC-1 cell line in this research?","Question",{"text":112,"@type":113},"The study uses PANC-1 as a reference in an in vitro model to investigate PIVKA-II production, distribution, and release in PDAC.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was PIVKA-II assessed in the panel of pancreatic cancer cell lines?",{"text":117,"@type":113},"PIVKA-II presence and levels were examined using Western blot analysis and indirect immunofluorescence (IFA), followed by quantitative evaluation.",{"name":119,"@type":110,"acceptedAnswer":120},"How does glucose concentration relate to PIVKA-II production and release?",{"text":121,"@type":113},"PIVKA-II production in PANC-1 appears directly related to increased glucose concentration in the culture medium, and release coincides with increasing glucose doses.",{"name":123,"@type":110,"acceptedAnswer":124},"What biological process is proposed to be linked with PIVKA-II release?",{"text":125,"@type":113},"The model suggests PIVKA-II release occurs jointly with epithelial–mesenchymal transition (EMT) activation, assessed via Vimentin and Snail expression.","https://schema.org",{"og:url":83,"og:type":128,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":130,"canonical":83},"index,follow",{"doc_id":132,"site_id":62},336083,1790148031,{"code":4,"msg":5,"data":135},{"doc_id":132,"user_id":136,"nickname":92,"user_avatar":137,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":138,"file_id":139,"file_url":140,"file_type":141,"file_size":142,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":52,"language":143,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":144,"faqs":145,"seo_title":146,"seo_description":67,"update_tm":147,"read_time":148,"preview_page_count":4},8796095360427,"https://ap-avatar.wpscdn.com/davatar_994ba38a5ba835b3df7d355c54d3ed8d","Article  \nPANC-1 Cell Line as an Experimental Model for Characterizing PIVKA-II Production, Distribution, and Molecular Mechanisms Leading to Protein Release in PDAC  \nAntonella Farina , Sara Tartaglione, Adele Preziosi, Patrizia Mancini , Antonio Angeloni  \nand Emanuela Anastasi *  \nCitation: Farina, A.; Tartaglione, S.; Preziosi, A.; Mancini, P.; Angeloni, A.; Anastasi, E. PANC-1 Cell Line as an Experimental Model for Characterizing PIVKA-II Production, Distribution, and Molecular Mechanisms Leading to Protein Release in PDAC. Int. J. Mol. Sci. 2024, 25, 3498. [https://doi.org/10.3390/](https://doi.org/10.3390/)[ ](https://doi.org/10.3390/)ijms25063498  \nAcademic Editors: Claudio Luchini and Donatella Delle Cave  \nReceived: 21 February 2024  \nRevised: 10 March 2024  \nAccepted: 13 March 2024  \nPublished: 20 March 2024  \nCopyright: © 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://](https://)[ ](https://)[creativecommons.org/licenses/by/](creativecommons.org/licenses/by/)[ ](creativecommons.org/licenses/by/)[4.0/](4.0/)) .  \nDepartment of Experimental Medicine, Sapienza University of Rome, Policlinico Umberto I, 00181 Rome, Italy;  \n[antoeffe22@gmail.com](antoeffe22@gmail.com) (A.F.); [sara.tartaglione@uniroma1.it](sara.tartaglione@uniroma1.it) (S.T.); [adelepreziosi@gmail.com](adelepreziosi@gmail.com) (A.P.);  \n[patrizia.mancini@uniroma1.it](patrizia.mancini@uniroma1.it) (P.M.); [antonio.angeloni@uniroma1.it](antonio.angeloni@uniroma1.it) (A.A.)  \n* Correspondence: [emanuela.anastasi@uniroma1.it](emanuela.anastasi@uniroma1.it)  \nAbstract: Pancreatic ductal adenocarcinoma (PDAC) represents a highly aggressive malignancy with a lack of reliable diagnostic biomarkers. Protein induced by vitamin K absence (PIVKA-II) is a protein increased in various cancers (particularly in hepatocellular carcinoma), and it has recently exhibited superior diagnostic performance in PDAC detection compared to other biomarkers. The aim of our research was to identify an in vitro model to study PIVKA-II production, distribution, and release in PDAC. We examined the presence of PIVKA-II protein in a panel of stabilized pancreatic cancer cell lines by Western blot analysis and indirect immunofluorescence (IFA) . After quantitative evaluation of PIVKA-II in PaCa 44, H-Paf II, Capan-1, and PANC-1, we adopted the latter as a reference model. Subsequently, we analyzed the effect of glucose addiction on PIVKA-II production in a PANC-1 cell line in vitro; PIVKA-II production seems to be directly related to an increase in glucose concentration in the culture medium. Finally, we evaluated if PIVKA-II released in the presence of increasing doses of glucose is concomitant with the expression of two well-acknowledged epithelial–mesenchymal transition (EMT) markers (Vimentin and Snail) . According to our experimental model, we can speculate that PIVKA-II release by PANC-1 cells is glucose-dependent and occurs jointly with EMT activation.  \nKeywords: PDAC; PIVKA-II; glucose; epithelial to mesenchymal transition  \n1. Introduction  \nNinety percent of pancreatic cancer cases are attributed to pancreatic ductal adenocarcinoma (PDAC), characterized by its aggressive and lethal nature [1] . With a 5-year survival rate of approximately 8%, PDAC stands as the sole cancer exhibiting an escalating mortality rate for both men and women. Nowadays, surgery remains the most radical treatment option for PDAC, but only 15–20% of cases are deemed surgically resectable at the time of diagnosis [2] . PDAC is in fact commonly referred to as the “silent killer”owing to its characteristic late diagnosis, with only 7% of cases identified at an early stage due to the absence of specific early symptoms; unfortunately, the tumor becomes apparent only after infiltrating surrounding tissues or metastasizing [3] . Given the tight correlation be","cbCaigEsGEB4tOmk","https://ap.wps.com/l/cbCaigEsGEB4tOmk","pdf",1211172,"English","# Introduction\n# Materials and Methods\n## Cell lines and in vitro experiments\n## PIVKA-II detection and quantification\n# Results\n## PIVKA-II expression in pancreatic cancer cell lines\n## Glucose dependence of PIVKA-II production and release\n## Link to EMT markers (Vimentin, Snail)\n# Conclusion","[{\"question\":\"What is the purpose of using the PANC-1 cell line in this research?\",\"answer\":\"The study uses PANC-1 as a reference in an in vitro model to investigate PIVKA-II production, distribution, and release in PDAC.\"},{\"question\":\"How was PIVKA-II assessed in the panel of pancreatic cancer cell lines?\",\"answer\":\"PIVKA-II presence and levels were examined using Western blot analysis and indirect immunofluorescence (IFA), followed by quantitative evaluation.\"},{\"question\":\"How does glucose concentration relate to PIVKA-II production and release?\",\"answer\":\"PIVKA-II production in PANC-1 appears directly related to increased glucose concentration in the culture medium, and release coincides with increasing glucose doses.\"},{\"question\":\"What biological process is proposed to be linked with PIVKA-II release?\",\"answer\":\"The model suggests PIVKA-II release occurs jointly with epithelial–mesenchymal transition (EMT) activation, assessed via Vimentin and Snail expression.\"}]","PANC-1 Cell Line as an Experimental Model for Characterizing PIVKA-II Production, Distribution, and Molecular Mechanisms Leading to Protein Release in PDAC | PDF",1790013544,25]